Home > News > Stock Profiler.US: Stock Profiler.US: Stock Watch: PNTV, NXHZ, TTCS, MCII
July 15th, 2009
Stock Profiler.US: Stock Profiler.US: Stock Watch: PNTV, NXHZ, TTCS, MCII
Abstract:
Mariner's Choice International Inc. closed at $0.00 Tuesday, trading 0 shares.
Company News- July 15, 2009: Mariner's Choice Completes Delivery of Initial Order to Private Label Partner
Mariner's Choice International Inc. (PINKSHEETS: MCII | Quote | Chart | News | PowerRating) earlier today announced that it has delivered 175 cases of products to a private label partner.
To read the full news release, go to www.stockprofiler.us, click the Headline Tab, enter the ticker symbol and click the news link.
About Mariner's Choice International Inc.
Mariner's Choice provides high-performance, eco-safe consumer and industrial products utilizing leading-edge biodegradable technologies. Each product is tested to exacting standards and performance levels, with the goal of providing the greatest benefit and satisfaction to our customers. Our "green" products, some of which employ nanotechnology, are a timely solution for the environmental and health concerns that affect people globally. For more information about us, please visit www.marinerschoice.net.
Source:
tradingmarkets.com
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||